Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Seattle Children's Hospital Molecular Genetics Laboratory, |
RCV002254287 | SCV002525686 | pathogenic | not provided | 2021-04-26 | criteria provided, single submitter | clinical testing | This variant has been previously reported in several unrelated individuals with arteriovenous malformations, and in vitro functional studies have demonstrated that the p.Lys57Asn substitution results in activation of downstream signaling (PMID: 28190454, PMID: 29461977). This variant has not been observed in large population studies (Genome Aggregation Database v2.1.1). |
Gene |
RCV000208748 | SCV000264640 | not provided | Cardio-facio-cutaneous syndrome | no assertion provided | literature only | ||
Database of Curated Mutations |
RCV000438528 | SCV000504534 | likely pathogenic | Melanoma | 2014-12-26 | no assertion criteria provided | literature only | |
Database of Curated Mutations |
RCV000421288 | SCV000504535 | pathogenic | Non-small cell lung carcinoma | 2014-10-02 | no assertion criteria provided | literature only | |
Database of Curated Mutations |
RCV000428485 | SCV000504536 | likely pathogenic | Lung adenocarcinoma | 2015-07-14 | no assertion criteria provided | literature only | |
OMIM | RCV002051691 | SCV001364400 | pathogenic | Melorheostosis | 2020-06-23 | no assertion criteria provided | literature only |